PRODUCTS OF ALTERNATIVELY SPLICED TRANSCRIPTS OF THE WILMS-TUMOR SUPPRESSOR GENE, WT1, HAVE ALTERED DNA-BINDING SPECIFICITY AND REGULATE TRANSCRIPTION IN DIFFERENT WAYS
Zy. Wang et al., PRODUCTS OF ALTERNATIVELY SPLICED TRANSCRIPTS OF THE WILMS-TUMOR SUPPRESSOR GENE, WT1, HAVE ALTERED DNA-BINDING SPECIFICITY AND REGULATE TRANSCRIPTION IN DIFFERENT WAYS, Oncogene, 10(3), 1995, pp. 415-422
The Wilms' tumor susceptibility gene, wt1, encodes a transcription fac
tor of the zinc finger protein family. Mutations in the WT1 gene produ
ct have been detected in both sporadic and familial Wilms' tumors, sug
gesting that alterations in WT1 may disrupt its normal function as a t
ranscriptional regulator. The transcripts of wt1 are alternatively spl
iced; however, roles of the alternatively spliced forms have not been
defined. The major transcript of wt1 encodes a WT1 protein [WT1(+KTS)17AA] that contains three amino acids (+KTS) between the third and fou
rth zinc fingers and a serine-rich, 17 amino acid (+17AA) domain N-ter
minal to the zinc finger region. We now show that the WT1(+KTS) forms
functionally bind to a unique G + C-rich sequence within the PDGF A-ch
ain promoter. We also show that WT1 (+KTS)+17AA functions as a strong
transciptional repressor and that +17AA alone fused to the zinc-finger
domain of WT1 or to the heterologous DNA binding domain of GAL4 funct
ions independently as a repressor. Deletion of four serine residues wi
thin +17AA abolishes the repressor activity of +17AA. These results in
dicate that wt1 products with +17AA contain an additional dominant rep
ressor domain and that the presence or absence of +KTS determines alte
rnative DNA binding specificity.